Eli Lilly and Company (LLY)

業務介紹

愛力莉莉（Eli Lilly and Company）是一家在全球範圍內發現、開發和銷售人用藥品的公司。該公司提供Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰島素利斯普羅、胰島素利斯普羅普坦、胰島素利斯普羅混合物 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R和Humulin U-500等治療糖尿病的藥物；以及Jardiance、Trajenta和Trulicity等治療2型糖尿病的藥物。該公司還提供Alimta用於非小細胞肺癌（NSCLC）和惡性胸膜間皮瘤；Cyramza用於轉移性胃癌、胃食道交界腺癌、轉移性NSCLC、轉移性結腸癌和肝細胞癌；Erbitux用於結腸癌和各種頭頸部癌症；Retevmo用於轉移性NSCLC、髓樣甲狀腺癌和甲狀腺癌；Tyvyt用於復發或難治的經典霍奇金淋巴瘤和非鱗狀NSCLC；以及Verzenio用於HR+、HER2-轉移性乳腺癌、淋巴結陽性和早期乳腺癌。該公司還提供Olumiant用於類風濕性關節炎；以及Taltz用於銀屑病、銀屑病性關節炎、強直性脊椎炎和非放射性軸索性脊椎炎。該公司還提供Cymbalta用於抑鬱症、糖尿病周邊神經病變性疼痛、廣泛性焦慮症、纖維肌痛症和慢性肌肉骨骼疼痛；Emgality用於頭痛預防和發作性叢集頭痛；以及Zyprexa用於精神分裂症、雙相I型障礙和雙相維持。該公司的Bamlanivimab和etesevimab，以及Bebtelovimab用於COVID-19；Cialis用於勃起功能障礙和良性前列腺增生；以及Forteo用於骨質疏鬆症。該公司與Incyte Corporation、Boehringer Ingelheim Pharmaceuticals, Inc.、AbCellera Biologics Inc.、Junshi Biosciences、Regor Therapeutics Group、Lycia Therapeutics, Inc.、Kumquat Biosciences Inc.、Entos Pharmaceuticals Inc.和Foghorn Therapeutics Inc.等公司合作。愛力莉莉（Eli Lilly and Company）成立於1876年，總部位於印第安納州印第安納波利斯市。

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

公司網址

https://www.lilly.com